Vanguard Capital Management
ATRC icon

Vanguard Capital Management’s AtriCure ATRC Stock Holding History

Vanguard Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.3M Buy
2,190,413
+34,649
+2% +$975K ﹤0.01% 1822
2026
Q1 		$61.5M Buy
+2,155,764
New +$73.6M ﹤0.01% 1746

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management's ATRC Position: Q2 2026 in Review

Vanguard Capital Management increased its AtriCure (ATRC) stake by 1.6% in Q2 2026, buying an estimated $975K and bringing the position to 2,190,413 shares worth $61.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Vanguard Capital Management first reported a position in ATRC in Q1 2026 and has held it in 2 quarters since. The position peaked at $61.5M in Q1 2026. 250 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Vanguard Capital Management held 2,190,413 shares of AtriCure worth $61.3M as of Q2 2026.
  • Vanguard Capital Management bought 34,649 AtriCure shares in Q2 2026, an estimated $975K.
  • AtriCure made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1822 holding.
  • Vanguard Capital Management first reported a position in AtriCure in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's AtriCure position peaked at $61.5M in Q1 2026.
  • 250 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.